Unknown

Dataset Information

0

Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.


ABSTRACT: Human influenza A virus (IAV) vaccination is limited by "antigenic drift," rapid antibody-driven escape reflecting amino acid substitutions in the globular domain of hemagglutinin (HA), the viral attachment protein. To better understand drift, we used anti-hemagglutinin monoclonal Abs (mAbs) to sequentially select IAV escape mutants. Twelve selection steps, each resulting in a single amino acid substitution in the hemagglutinin globular domain, were required to eliminate antigenicity defined by monoclonal or polyclonal Abs. Sequential mutants grow robustly, showing the structural plasticity of HA, although several hemagglutinin substitutions required an epistatic substitution in the neuraminidase glycoprotein to maximize growth. Selecting escape mutants from parental versus sequential variants with the same mAb revealed distinct escape repertoires, attributed to contextual changes in antigenicity and the mutation landscape. Since each hemagglutinin mutation potentially sculpts future mutation space, drift can follow many stochastic paths, undermining its unpredictability and underscoring the need for drift-insensitive vaccines.

SUBMITTER: Das SR 

PROVIDER: S-EPMC3747226 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.

Das Suman R SR   Hensley Scott E SE   Ince William L WL   Brooke Christopher B CB   Subba Anju A   Delboy Mark G MG   Russ Gustav G   Gibbs James S JS   Bennink Jack R JR   Yewdell Jonathan W JW  

Cell host & microbe 20130301 3


Human influenza A virus (IAV) vaccination is limited by "antigenic drift," rapid antibody-driven escape reflecting amino acid substitutions in the globular domain of hemagglutinin (HA), the viral attachment protein. To better understand drift, we used anti-hemagglutinin monoclonal Abs (mAbs) to sequentially select IAV escape mutants. Twelve selection steps, each resulting in a single amino acid substitution in the hemagglutinin globular domain, were required to eliminate antigenicity defined by  ...[more]

Similar Datasets

| S-EPMC2784927 | biostudies-literature
| S-EPMC5008105 | biostudies-literature
| S-EPMC5863095 | biostudies-literature
| S-EPMC5668287 | biostudies-literature
| S-EPMC7077184 | biostudies-literature
| S-EPMC4613558 | biostudies-literature
| S-EPMC3251064 | biostudies-literature
| S-EPMC3165837 | biostudies-literature
| S-EPMC6116000 | biostudies-literature
| S-EPMC10444018 | biostudies-literature